C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2007
11/28/2007	EP1565559A4 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same
11/28/2007	EP1542710A4 Methods for preserving organs and tissues
11/28/2007	EP1434482B9 Methods for growing and imprinting fish using an odorant
11/28/2007	EP1419253B1 Isolation of proteins involved in posttranscriptional gene silencing and methods of use
11/28/2007	EP1302104B1 P300 transgenic animal
11/28/2007	EP1190081B1 Plants with modified gene expression
11/28/2007	EP1115863B1 Ucp4
11/28/2007	EP1019077B1 Novel exendin agonist compounds
11/28/2007	EP0991666B1 Alpha 1-antitrypsin preparation and method for the production thereof
11/28/2007	EP0977844B1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof
11/28/2007	EP0959682B1 Therapeutic applications of laminin and laminin-derived protein fragments
11/28/2007	EP0957934B1 Targeting antigens to the mhc class i processing pathway with anthrax toxin fusion protein
11/28/2007	EP0937103B1 Compounds and methods for modulating cell adhesion
11/28/2007	EP0910387B1 Apoptosis associated protein bbk
11/28/2007	CN101080420A A thymus-specific protein
11/28/2007	CN101080419A Compositions and methods of using angiopoietin-like 4 protein
11/28/2007	CN101080239A Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis
11/28/2007	CN101080238A Compositions and methods for the preparation of human growth hormone glycosylation mutants
11/28/2007	CN101080237A Antiviral agents for the treatment, control and prevention of infections by coronaviruses
11/28/2007	CN101078017A Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
11/28/2007	CN101078016A Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins
11/28/2007	CN101078015A Korshinsk peashrub transcription factor CkAREB and application of the same in adversity resistant plant cultivation
11/28/2007	CN101078013A Identification and application of neurotrophy factor BDNF and NT-3 signal path new component Dok5
11/28/2007	CN101077889A Polypeptide similar to growth factor and maintenance product
11/28/2007	CN101077887A Human accelerated haematogenous cell proliferated cytokine, preparation method and use thereof
11/28/2007	CN101077886A Recombination protein AMACR and application of the same in preparing prostate cancer diagnosis label
11/28/2007	CN101077885A New antitumoral compounds
11/28/2007	CN100351375C In vitro peptide expression library
11/28/2007	CN100351272C Technological process of preparing collagen peptide with starfish shell
11/28/2007	CN100351271C Active polypeptide of brown-spotted torrential frog, its gene and application in drug preparation
11/28/2007	CN100351270C Antibacterial peptide of brown-spotted torrential frog, its gene and application in drug preparation
11/28/2007	CN100351269C Pseudomonas pseudoalcaligenes disinsection protein gene
11/28/2007	CN100351268C Peptides from the e2, e6 and e7 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other cancers
11/28/2007	CN100351243C Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones
11/28/2007	CN100350980C Method for preparing 131I marker GM-CSF protein for treating leukemia
11/27/2007	US7301071 Method for the production of plant seed with modified fiber content and modified seed coat
11/27/2007	US7301068 Nonhuman model animal of Th2-mediated hyperimmune response
11/27/2007	US7301041 Bi-functional metallocenes, preparation process and use in the labeling or biological molecules
11/27/2007	US7301037 Charged compounds comprising a nucleic acid binding moiety and uses therefor
11/27/2007	US7301016 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosing and treating cell proliferative disorders; animal models
11/27/2007	US7301014 Nucleic acid molecule encoding a novel estrogen receptor beta variant
11/27/2007	US7301010 A chemically modified bacterial cupredoxin peptide formulated for injection, inhalation, oral and topical administration, transdermal patches, and suppositories; synergistic administration
11/27/2007	US7301009 Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli
11/27/2007	US7301008 PRO7174 polypeptides
11/27/2007	US7301007 PRO4340 polypeptides
11/27/2007	US7301006 Methods and materials for the synthesis of modified peptides
11/27/2007	US7301005 Immunomodulatory peptides derived from heat shock proteins and uses thereof
11/27/2007	US7300942 For therapy of a fungal infection
11/27/2007	US7300929 Mediators of hedgehog signaling pathways, compositions and uses related thereto
11/27/2007	US7300920 N-terminal sequences of human growth hormone, human placental lactogen, human growth hormone variant hGH-V, and prolactin; used in inhibiting angiogenesis and in the diagnosis of diseases of human pregnancy involving abnormal placental
11/27/2007	US7300919 Pulmonary delivery of active fragments of parathyroid hormone
11/27/2007	US7300918 Method of producing vaccines from protein signal oligopeptides
11/27/2007	US7300916 Use of an erythropoietin antagonist for manufacture of a pharmaceutical preparation for preventing and/or treating hypertrophic scars, keloid or chronic arthritic diseases.
11/27/2007	US7300915 Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
11/27/2007	US7300791 Nucleotide sequences coding polypeptide for use in the treatment heart injury and diabetic ulcer
11/27/2007	US7300790 Transgenic animals expressing transdominant negative retroviral nucleic acids and proteins
11/27/2007	US7300778 Of given amino acid sequence; screening for modulator ligands; vectors, antisense transcripts or mutants
11/27/2007	US7300774 Injected locally as a vaccine adjuvant or tumor immunotherapy agent to prevent them from diffusing away
11/27/2007	US7300772 Bone morphogenic protein for use in the treatment of bone disorders; for use as wound healing agent
11/27/2007	US7300764 Method for identifying agonists and antagonists of the GPR45-like/GPR63 receptor
11/27/2007	US7300762 Introducing into a cell a nucleic acid molecule comprising a nucleotide sequence encoding a modified Green Fluorescent Protein (GFP) fused to a nucleotide sequence encoding a protein of interest; culturing; determining the cellular and/or extracellular localisation of protein by detecting fluorescence
11/27/2007	US7300759 Use of tramdorins in diagnostic and therapeutic methods
11/27/2007	US7300753 immunoglobulin which binds phosphorylated ubiquitin fusion degradation protein 1 (UFD1) for use in diagnosis, prevention and treatment of cardiovascular and cell proliferative disorders
11/27/2007	US7300749 Molecules of the pyrin domain protein family and uses thereof
11/27/2007	US7300678 Using white almond paste; prevent wrinkling of skins
11/27/2007	US7300663 Adhesion and sealing of tissue with compositions containing polyfunctional crosslinking agents and protein polymers
11/27/2007	US7300660 immunogens/vaccines against mycobactium tuberculosis
11/27/2007	US7300659 Comprising an enterohemorragic Escherichia coli (EHEC) cell culture supernatant and an immunological adjuvant
11/27/2007	US7300657 Recombinant viral-based malaria vaccines
11/27/2007	US7300656 Treatment of inflammatory bowel disease with IFN-gamma inhibitors
11/27/2007	US7300654 Method of treating corneal transplant rejection in high risk keratoplasty patients
11/27/2007	US7300653 Method of treating corneal transplant rejection
11/27/2007	US7300652 Contacting cell expressing kidney injury-molecule-1 (KIM-1) cell surface polypeptide with an effective amount of an isolated antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide
11/27/2007	CA2303061C Lunasin peptides
11/27/2007	CA2301174C A method for inducing therapeutically-effective proteins
11/27/2007	CA2208751C Oil body proteins as carriers of high value proteins
11/27/2007	CA2100616C Receptor identification method
11/27/2007	CA1341562C Gene coded for interleukin-2 polypeptide, recombinant dna carrying the said gene, a living cell line possessing the recombinant dna, and method for producing interleukin-2 using the said cell
11/25/2007	CA2575507A1 Quantification of vitellogenin
11/25/2007	CA2549079A1 Quantification of vitellogenin
11/22/2007	WO2007134303A2 Modified bacteriocins and methods for their use
11/22/2007	WO2007134272A2 Humanized models via targeted mtagenesis with zinc finger nuclease
11/22/2007	WO2007133994A2 System and method for taking risk out of driving
11/22/2007	WO2007133811A2 Cd47 related compositions and methods for treating immunological diseases and disorders
11/22/2007	WO2007133776A2 Active delivery and flow redirection: novel devices and method of delivery of materials to patients
11/22/2007	WO2007133623A2 Peptide diagnostic agent for lyme disease
11/22/2007	WO2007133595A2 Integrated vacuum absorption steam cycle gas separation
11/22/2007	WO2007133425A2 Fungal delta12 desaturase and delta15 desaturase motifs
11/22/2007	WO2007133373A2 TNF-α VACCINE FOR TREATING DISEASE CONDITIONS MEDIATED BY PATHOLOGICAL TNF-α
11/22/2007	WO2007133153A1 Improved antimicrobial peptides
11/22/2007	WO2007132789A1 Method for production of cleistogamous rice and method for selection of cleistogamous rice
11/22/2007	WO2007132555A1 Cell membrane-permeable peptide and utilization of the same in cell
11/22/2007	WO2007132481A2 Novel thrombolytic molecules and a process therefor
11/22/2007	WO2007132193A1 Modified vird2 protein and its use in improved gene transfer
11/22/2007	WO2007132177A1 HlSTONES
11/22/2007	WO2007132096A2 System for transposing hyperactive recombinant derivatives of mos-1 transposon
11/22/2007	WO2007132037A1 Method for synthesizing thymosins
11/22/2007	WO2007131778A2 Diagnostic and therapeutic uses of peptides for pre-forms of type 2 diabetes and conditions associated therewith
11/22/2007	WO2007131363A1 Monoclonal antibodies to anthrax protective antigen
11/22/2007	WO2007131352A1 High-affinity antagonists of elr-cxc chemokines

1 ... 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 ... 2916